Physician profile
Serdar Farhan
NPI 1417495508
$30,987.42
in general payments reported to CMS, 2019-2025
36 companies · $9,817 in 2025
The $9,817 reported for 2025 was more than what 89% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $2,209 · 2021: $5,756 · 2022: $9,293 · 2023: $2,935 · 2024: $978 · 2025: $9,817.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,567 · Food and Beverage: $6,162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,567.09 |
| Food and Beverage | $6,162.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $9,429.06 | 2021-2025 | Symplicity G3, Corevalve Evolut R, Hawkone |
| Abbott Laboratories | $4,284.85 | 2021-2025 | Esprit, Diamondback Peripheral, Mitraclip |
| Shockwave Medical, INC | $4,254.93 | 2020-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $2,048.00 | 2020-2025 | General - Therapies, Watchman Access System, Rotapro |
| Edwards Lifesciences Corporation | $986.08 | 2022-2024 | Pascal, Sapien 3 Ultra Resilia |
| Ancora Heart, INC. | $943.00 | 2023 | Accucinch |
| Amgen INC. | $832.45 | 2020-2024 | Repatha |
| Cardiovascular Systems INC. | $809.07 | 2020-2022 | |
| Biotronik INC. | $794.44 | 2021-2025 | Biomonitor |
| Terumo Medical Corporation | $618.21 | 2020-2023 | Glidewire |
| Janssen Pharmaceuticals, INC | $567.60 | 2020-2023 | Xarelto |
| Astrazeneca Pharmaceuticals Lp | $564.19 | 2020-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $545.81 | 2020-2024 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $472.59 | 2020-2023 | Camzyos |
| Chiesi USA, INC. | $452.07 | 2020-2023 | Kengreal |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $422.79 | 2020-2023 | |
| Bard Peripheral Vascular, INC. | $404.63 | 2020-2023 | Lutonix Drug Coated Balloon |
| Endologix LLC | $397.20 | 2025 | Endocross Device, Torus Stent Graft System |
| Abiomed | $364.78 | 2020-2021 | |
| Stryker Corporation | $350.32 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Limflow System |
| Pfizer INC. | $300.93 | 2020-2022 | |
| Cagent Vascular INC | $197.83 | 2023-2025 | Serrantor |
| Cook Medical LLC | $133.30 | 2022-2023 | Zilver Ptx, Cook Celect |
| Veryan Medical Incorporated | $131.49 | 2022 | |
| W. L. Gore & Associates, INC. | $100.09 | 2021-2023 | Gore Cardioform Septal Occluder |
| Penumbra, INC. | $93.07 | 2020 | |
| Cardiva Medical, INC. | $88.18 | 2020-2021 | |
| Cordis US Corp. | $87.86 | 2021 | |
| Advanced Oxygen Therapy INC. | $67.87 | 2020 | |
| Asahi Intecc USA, INC. | $49.55 | 2022 | |
| Medtronic Vascular, INC. | $46.02 | 2020 | |
| Acist Medical Systems, INC. | $43.16 | 2022 | |
| Inari Medical, INC. | $31.06 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Heartflow, INC. | $28.08 | 2022 | |
| Teleflex LLC | $28.07 | 2022 | |
| Merck Sharp & Dohme LLC | $18.79 | 2023 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Serdar Farhan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.